Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-064516

Chief Financial Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2026-05-18 Option exercise +3,000 $17.87 $53,610 119,611 D
Derivatives
Smith Hunter C Chief Financial Officer 2026-05-18 Option exercise · Stock Options (Right to Buy) −3,000 79,000 D
Loading xslF345X06/tm2615222-1_4seq1.xml…